Axonics Inc. (AXNX) Financial Statements (2024 and earlier)

Company Profile

Business Address 26 TECHNOLOGY DRIVE
IRVINE, CA 92618
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments344,960357,211220,878241,181183,674157,524
Cash and cash equivalents104,811238,846220,878241,181171,08298,306
Short-term investments240,149118,365  12,59259,218
Receivables57,24344,81729,04418,2707,879427
Inventory, net of allowances, customer advances and progress billings79,94055,76564,94663,06015,6593,673
Inventory79,94055,76564,94663,06015,6593,673
Other undisclosed current assets9,2797,2826,4495,4354,4683,716
Total current assets:491,422465,075321,317327,946211,680165,340
Noncurrent Assets
Operating lease, right-of-use asset22,500    
Property, plant and equipment  6,7986,9156,3283,0472,784
Intangible assets, net (including goodwill)180,792180,667211,979196311426
Goodwill99,41794,414105,510   
Intangible assets, net (excluding goodwill)81,37586,253106,469196311426
Other noncurrent assets24,2356,8137,7347,7364,7843,356
Other undisclosed noncurrent assets974     
Total noncurrent assets:228,501194,278226,62814,2608,1426,566
TOTAL ASSETS:719,923659,353547,945342,206219,822171,906
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities28,97915,59025,50223,29211,4315,119
Employee-related liabilities12,4135,9483,375 
Accounts payable18,4529,0707,65410,6605,8823,436
Accrued liabilities10,5276,5205,4356,6842,1741,683
Debt    21,110602 
Other liabilities  32,600    
Other undisclosed current liabilities16,83717,0571,3661,280 768
Total current liabilities:45,81665,24726,86845,68212,0335,887
Noncurrent Liabilities
Long-term debt and lease obligation   9,0529,15424,78619,463
Long-term debt, excluding current maturities     20,33619,463
Liabilities, other than long-term debt36,54323,96729,587   
Deferred income tax liabilities10,70316,41219,217  
Other liabilities   10,370   
Operating lease, liability25,8407,5559,0529,1544,450
Other undisclosed noncurrent liabilities    (9,154) 3,281
Total noncurrent liabilities:36,54323,96738,6399,15424,78622,744
Total liabilities:82,35989,21465,50754,83636,81928,631
Equity
Equity, attributable to parent637,564570,139482,438287,370183,003143,275
Common stock555433
Additional paid in capital1,033,778969,545803,559522,296363,012243,337
Accumulated other comprehensive loss(15,867)(25,147)(6,560)(431)(428)(416)
Accumulated deficit(380,352)(374,264)(314,566)(234,499)(179,584)(99,649)
Total equity:637,564570,139482,438287,370183,003143,275
TOTAL LIABILITIES AND EQUITY:719,923659,353547,945342,206219,822171,906

Income Statement (P&L) ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues366,379273,702180,290111,53513,820707
Cost of revenue
(Cost of Goods and Services Sold)
(91,825)(76,037)(64,572)(44,444)(6,490)(356)
Gross profit:274,554197,665115,71867,0917,330351
Operating expenses(300,611)(262,611)(187,526)(120,851)(87,929)(32,488)
Operating loss:(26,057)(64,946)(71,808)(53,760)(80,599)(32,137)
Nonoperating income (expense)17,3132,630(7,477)(1,154)665(345)
Investment income, nonoperating   407612,974998
Other nonoperating income (expense)624(2,434)(7,426)(1,874)(2,309)(1,343)
Interest and debt expense    (774)(873)(338)
Loss from continuing operations before equity method investments, income taxes:(8,744)(62,316)(79,285)(55,688)(80,807)(32,820)
Other undisclosed income from continuing operations before income taxes    774873338
Loss from continuing operations before income taxes:(8,744)(62,316)(79,285)(54,914)(79,934)(32,482)
Income tax expense (benefit)2,6562,618(782)(1)(1)(1)
Loss from continuing operations:(6,088)(59,698)(80,067)(54,915)(79,935)(32,483)
Loss before gain (loss) on sale of properties:(80,067)(54,915)(79,935)(32,483)
Net loss available to common stockholders, diluted:(6,088)(59,698)(80,067)(54,915)(79,935)(32,483)

Comprehensive Income ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(6,088)(59,698)(80,067)(54,915)(79,935)(32,483)
Comprehensive loss:(6,088)(59,698)(80,067)(54,915)(79,935)(32,483)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent9,280(18,587)(6,129)(3)(12)(14)
Comprehensive income (loss), net of tax, attributable to parent:3,192(78,285)(86,196)(54,918)(79,947)(32,497)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: